Synonyms | Schwarz brand of valsartan I997 4997-EP2308562A2 Spectrum_001796 KBioGR_001078
AB00639940-08 UNII-80M03YXJ7I L-Valsartan ACT02671 valsartan (Diovan) MolPort-002-507-854 Aventis brand of valsartan Valsartan, European Pharmacopoeia (EP) Reference Standard N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine BRD-K45158365-001-02-3 Varexan CGP-48933 (2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid D06UDG (S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Novartis brand of valsartan Esteve brand of valsartan 2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid RTR-031794 HMS2051L12 4997-EP2295422A2 SPECTRUM1505209 Kalpress ST2408288 KS-1194 AB07510 VAL-489 MCULE-6728882368 AKOS015914315 Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine BCP05184 Valsartan,(S) N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine C24H29N5O3 (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid [3H]valsartan CHEMBL1069 (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid Diovan (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine Pharmakon1600-01505209 FT-0631156 SAM001246581 HMS3651E04 4997-EP2298779A1 4997-EP2301936A1 Spectrum4_000749 KBio2_007423 AB0013966 TL8000869 L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI) AC1L1U1M Valsarran MLS000759423 AN-7255 Valsartan [USAN:USP:INN:BAN] N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE BIDD:GT0345 Valzaar CEPA brand of valsartan (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid D00400 (s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid NC00278 DS-1248 137862-53-4 Provas GTPL593 4997-EP2277879A1 SC-00971 HY-18204 SMR000466318 J-007068 4997-EP2308839A1 SR-05000001928 KBioSS_002289 AB00639940_09 V-120 Lacer brand of valsartan ACWBQPMHZXGDFX-QFIPXVFZSA-N Valsartan (JAN/USAN/INN) MolPort-003-666-608 AX8018200 Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine BRD-K45158365-001-05-6 walsartan CHEBI:9927 (5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid (S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid NSC-758927 Exforge 3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid S-6418 HMS2093K22 4997-EP2298772A1 4997-EP2301923A1 Spectrum2_001120 KBio2_002287 62V534 SW197658-2 L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)- AB2000354 Valpression MFCD00865840 AKOS015994698 Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine BDBM50049186 Valtan N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine CCG-101028 (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid CPD000466318 (s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid N-Valeryl-N-[2'-(5-tetrazolyl)biphenyl-4-ylmethyl]-L-valine Diovan (TN) (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine Prexxartan GP8514 4997-EP2270011A1 Sanol brand of valsartan HMS3715P12 4997-EP2305219A1 Spectrum5_001582 KBio3_003006 AB00639940-06 TR-031794 L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- AC1Q5QIK MLS001424088 ANW-49040 Valsartan, >=98% (HPLC) N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine BR-58790 Valzaar (TN) CGP 48933 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid. D04HSR (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Nisis EC 604-045-2 137863-60-6 PubChem9865 HMS1922L21 4997-EP2295406A1 SCHEMBL2542 I14-41498 SPBio_001260 J10013 SR-05000001928-1 KS-00000ISS AB00639940_11 VA11929 LS-161334 AK-58790 Valsartan (JP17/USAN/INN) N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine BC204156 Valsartan, United States Pharmacopeia (USP) Reference Standard N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine BSPBio_003501 (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid ZINC3875259 (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid DB00177 (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine NSC758927 EZR-104 3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid s1894 HMS2232F05 4997-EP2298776A1 4997-EP2301931A1 Spectrum3_001831 KBio2_004855 80M03YXJ7I Tareg L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- AC-4543 Vals Miten AM90287 Valsartan [USAN:INN] N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine BG0645 Valtan (TN) CCG-221275 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid CS-1967 (S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine Diovan, Valsartan (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine Prexxartan (oral solution) GTPL3937 4997-EP2272841A1 SBI-0206738.P001 HSDB 7519 [ Show all ] |
---|
Inchi ID | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 |
---|